A detailed history of Raymond James Financial Inc transactions in Liquidia Corp stock. As of the latest transaction made, Raymond James Financial Inc holds 39,064 shares of LQDA stock, worth $1.12 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
39,064
Previous 37,515 4.13%
Holding current value
$1.12 Million
Previous $467,000 91.86%
% of portfolio
0.0%
Previous 0.0%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 14, 2025

BUY
$12.06 - $28.85 $18,680 - $44,688
1,549 Added 4.13%
39,064 $896,000
Q2 2025

Aug 14, 2025

SELL
$11.99 - $19.3 $192,559 - $309,958
-16,060 Reduced 29.98%
37,515 $467,000
Q1 2025

May 13, 2025

BUY
$11.36 - $16.5 $398,372 - $578,622
35,068 Added 189.49%
53,575 $790,000
Q4 2024

Feb 06, 2025

BUY
$9.82 - $11.8 $181,738 - $218,382
18,507 New
18,507 $217,000

Others Institutions Holding LQDA

About Liquidia Corp


  • Ticker LQDA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 64,362,300
  • Market Cap $1.84B
  • Description
  • Liquidia Corporation, a biopharmaceutical company, develops, manufactures, and commercializes various products for unmet patient needs in the United States. Its product candidates include YUTREPIA, an inhaled dry powder formulation of treprostinil for the treatment of pulmonary arterial hypertension. It also distributes generic treprostinil inje...
More about LQDA
Track This Portfolio

Track Raymond James Financial Inc Portfolio

Follow Raymond James Financial Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Raymond James Financial Inc, based on Form 13F filings with the SEC.

News

Stay updated on Raymond James Financial Inc with notifications on news.